Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Revvity, Inc. Common Stock (NY: RVTY )

115.01 +3.27 (+2.93%)
Official Closing Price Updated: 4:10 PM EST, Feb 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Revvity, Inc. Common Stock

< Previous 1 2 Next >
Uncover the latest developments among S&P500 stocks in today's session.
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations
Life sciences company Revvity (NYSE:RVTY) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.8% year on year to $729.4 million. On the other hand, the company’s full-year revenue... 
Via StockStory
Friday's pre-market session: top gainers and losers in the S&P500 index
Get insights into the top gainers and losers in the S&P500 index of Friday's pre-market session. 
Via Chartmill
Earnings Scheduled For January 31, 2025
Via Benzinga
(RVTY) - Analyzing Revvity's Short Interest
Via Benzinga
Forecasting The Future: 7 Analyst Projections For Revvity
Via Benzinga
Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst
BofA upgrades Danaher and Revvity, predicting a mixed but improving outlook for life sciences tools in fiscal year 2025 amid ongoing market challenges. 
Via Benzinga
These Analysts Revise Their Forecasts On Revvity Following Q3 Results
Via Benzinga
Assessing Revvity: Insights From 8 Financial Analysts
Via Benzinga
Looking Into Revvity's Recent Short Interest
Via Benzinga
Wall Street Rises Ahead Of Big Tech Earnings, Fed Meeting; Tesla Rebounds, Oil Prices Drop To 7-Week Lows: What's Driving Markets Monday?
Wall Street opened higher at the start of a data-heavy week, with traders adopting an optimistic tone ahead of crucial earnings reports and economic events. 
Via Benzinga
Topics Economy
Exposures Interest Rates
RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q2 2024
RVTY stock results show that Revvity beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Life Science Firm Revvity Lifts Annual Profit Forecast On Strong Q2 Performance
Revvity reported Q2 sales of $691.69 million, surpassing estimates, with adjusted EPS of $1.22. Life Sciences revenue fell 7%, while Diagnostics sales rose 1%. Updated 2024 guidance includes sales of... 
Via Benzinga
4 Analysts Have This To Say About Revvity
Via Benzinga
RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q1 2024
RVTY stock results show that Revvity beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Enphase Energy Reports Weak Results, Joins Lithia Motors And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
The Latest Analyst Ratings For Revvity
Via Benzinga
Peeling Back The Layers: Exploring Revvity Through Analyst Insights
Via Benzinga
7 Analysts Have This to Say About Revvity
Via Benzinga
Why Revvity Stock Plunged Today
Revvity announced disappointing results and lowered its full-year outlook. Here's what investors need to know. 
Via The Motley Fool
US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?
U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events including earnings reports from tech giants like Amazon.com Inc.... 
Via Benzinga
Why Biotechnology Company Revvity's Shares Diving Today
Revvity Inc (NYSE: RVTY) shares are trading lower by around 17% after the company reported worse-than-expected Q3 FY23 results and  
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Earnings Outlook For Revvity
Via Benzinga
What 6 Analyst Ratings Have To Say About Revvity
Via Benzinga
Earnings Scheduled For February 1, 2024
Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on... 
Via Benzinga
Earnings Preview For Revvity
Via Benzinga
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash. 
Via Benzinga
Earnings Scheduled For October 30, 2023
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 369 companies hit new 52-week lows. 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.